cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Collegium Pharmaceutical Inc
5 own
16 watching
Current Price
$25.6
$-0.03
(-0.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
758.71M
52-Week High
52-Week High
30.22000
52-Week Low
52-Week Low
20.83000
Average Volume
Average Volume
0.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
7.3718
iconMarket Capitalization758.71M
icon52-Week High30.22000
icon52-Week Low20.83000
iconAverage Volume0.28M
iconDividend Yield--
iconP/E Ratio7.3718
What does the Collegium Pharmaceutical Inc do?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. It offers Xtampza, an oral formulation of oxycodone, for the management of pain. The company also develops Onsolis, a transmucosal immediate-release fentanyl film indicated for the management of breakthrough pain in cancer patients 18 years of age and older. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Read More
How much money does Collegium Pharmaceutical Inc make?
News & Events about Collegium Pharmaceutical Inc.
Globe Newswire
9 months ago
Highlights 2022 environmental, social and governance achievementsSTOUGHTON, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced the release of its inaugural Environmental, Social and ...
Globe Newswire
9 months ago
STOUGHTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the pricing of its offering of $210,000,000 aggregate principal amount of 2.875% convertible senior notes due 2029 (the notes) in a private offering to qualified institutional buyers ...
Globe Newswire
11 months ago
Product Revenues, Net Expected in the Range of $565.0 Million to $580.0 Million Adjusted Operating Expenses* Expected in the Range of $135.0 Million to $145.0 Million Adjusted EBITDA* Expected in the Range of $355.0 Million to $370.0 Million $100 Million Share Repurchase Program Authorized by the ...
Globe Newswire
11 months ago
Mike Heffernan appointed Chairman of NMD Pharmas Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen several successful IPOs and trade sales Aarhus, Denmark, 3 January 2023 NMD Pharma A/S, a ...
Globe Newswire
11 months ago
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expirySTOUGHTON, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that the Federal Circuit has upheld the judgment of ...
Frequently Asked Questions
Frequently Asked Questions
What is Collegium Pharmaceutical Inc share price today?
plus_minus_icon
Can Indians buy Collegium Pharmaceutical Inc shares?
plus_minus_icon
How can I buy Collegium Pharmaceutical Inc shares from India?
plus_minus_icon
Can Fractional shares of Collegium Pharmaceutical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Collegium Pharmaceutical Inc stocks?
plus_minus_icon
What is today’s traded volume of Collegium Pharmaceutical Inc?
plus_minus_icon
What is today’s market capitalisation of Collegium Pharmaceutical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Collegium Pharmaceutical Inc?
plus_minus_icon
What percentage is Collegium Pharmaceutical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Collegium Pharmaceutical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$25.6
$-0.03
(-0.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Seres Therapeutics Inc
Seres Therapeutics Inc
$1.07
$0.03 (2.88 %)
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc.
$7.25
$-0.60 (-7.64 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$7.24
$0.47 (6.94 %)
Omeros Corporation
Omeros Corporation
$2.23
$0.04 (1.83 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Seres Therapeutics Inc
Seres Therapeutics Inc
$1.07
$0.03 (2.88 %)
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc.
$7.25
$-0.60 (-7.64 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$7.24
$0.47 (6.94 %)
Omeros Corporation
Omeros Corporation
$2.23
$0.04 (1.83 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00